Studies show that there are few if any, additional side effects from the COVID-19 vaccine for people with eczema. In one ...
A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals 12 years and older with eczema that is not sufficiently controlled with ...
which is an injection just under the skin. The trial is looking at a new drug, LEO 138559, for the treatment of moderate to severe eczema. Eczema is a chronic disease that causes inflammation ...